Why Patients Switch GLP-1 Medications: Cost & Convenience
Wegovy Dose Chart: Your Complete Switching Guide
The Wegovy dose chart follows a structured escalation schedule, making it easier to switch from other GLP-1 medications. Starting at 0.25mg for weeks 1-4, the dose increases every four weeks: 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and maintenance at 2.4mg from week 17 onwards. This gradual progression helps minimise side effects during transition. Patients switching from Mounjaro often find the dose escalation more gentle, whilst those moving from Ozempic appreciate the weight-specific licensing. Your prescriber will determine the appropriate starting dose based on your current medication and tolerance.
The Wegovy dose chart provides clear conversion guidance for healthcare professionals. Most patients switching from 2.5mg Mounjaro typically start Wegovy at 0.5mg or 1mg, depending on tolerance and time since last injection. Those transitioning from 1mg Ozempic usually begin at the 0.5mg Wegovy dose. However, individual responses vary significantly, and some patients may need to restart from 0.25mg to ensure comfortable transition. Your prescriber will create a personalised switching plan based on your medical history and current response to GLP-1 therapy.
Switch & Save: Wegovy Dose Chart Pricing Comparison
Our Wegovy dose chart reveals significant savings compared to Mounjaro, particularly on maintenance doses. The 2.4mg Wegovy maintenance dose costs £209.99, whilst equivalent Mounjaro doses exceed £350 monthly through many suppliers. New customers save further with code FIRST40 applied at checkout, bringing starter doses down to £79.99. Returning customers benefit from DOSE25 for ongoing savings. These discounts are automatically calculated to reach our competitive final prices, ensuring transparent pricing throughout your switching journey.
Bundle options provide additional convenience for patients following our Wegovy dose chart progression. The Progress Trio (0.5mg, 1mg & 1.7mg) offers three months of escalation for £369.99, perfect for patients switching from lower-dose GLP-1 medications. The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring consistent treatment without monthly reordering. Bundles eliminate the risk of treatment gaps during switching, maintaining therapeutic continuity whilst you transition between medications.
Clinical Evidence Supporting Wegovy Dose Chart Effectiveness
The structured Wegovy dose chart is based on extensive clinical evidence from the STEP trial programme. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The dose escalation schedule proved crucial for minimising gastrointestinal side effects whilst maximising therapeutic benefit.
STEP 5 demonstrated sustained effectiveness, with patients maintaining approximately clinically studied weight loss at two years when following the complete Wegovy dose chart progression. The recent SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events (HR 0.80), providing additional benefits beyond weight management. These results support the switching decision for patients seeking evidence-based weight management with proven cardiovascular benefits.
How Wegovy Works: Understanding the Wegovy Dose Chart Mechanism
Each dose in the Wegovy dose chart delivers semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. The medication works on brain appetite centres, reducing hunger signals and promoting satiety after smaller meals. Unlike stimulant-based weight loss medications, Wegovy addresses the underlying hormonal pathways that regulate appetite and food intake. The gradual dose increases allow your body to adapt to the medication's effects, reducing the likelihood of nausea or other gastrointestinal side effects. This mechanism explains why patients switching from other approaches often find Wegovy more sustainable for long-term weight management alongside a reduced-calorie diet and increased physical activity.
Ordering Process: Getting Your Wegovy Dose Chart Started
Switching to Wegovy through EverydayMeds takes just minutes with our streamlined process. Complete our 3-minute online clinical assessment, providing details about your current medication, dosing history, and reasons for switching. Our prescribers review switching requests with particular attention to ensuring safe transition protocols. Standard prescriber review takes 3 working days, though express 24-hour review is available for urgent switches. Once approved, your Wegovy ships via next-day delivery in temperature-controlled packaging, maintaining the cold-chain integrity essential for this prescription-only medicine. Our GPhC-registered pharmacy (#9012878) ensures you receive authentic Novo Nordisk FlexTouch pens with full support documentation.
Storage & Practical Considerations for Your Wegovy Dose Chart
Proper storage is crucial when following any Wegovy dose chart progression. Store unopened pens in your fridge at 2-8°C, though they remain stable for up to 6 weeks at room temperature below 30°C once removed. This storage flexibility gives Wegovy a travel advantage over Mounjaro's 21-day room temperature limit. Each FlexTouch pen contains four doses, administered weekly on the same day. The dose escalation cannot be accelerated - you must complete each four-week period before progressing to the next strength. Mark your calendar with dose increase dates to maintain the proper Wegovy dose chart timeline for optimal results and minimal side effects.
Wegovy Dose Chart: Addressing Common Switching Concerns
Many patients worry about losing progress when switching medications, but the Wegovy dose chart is designed to maintain therapeutic continuity. Most patients experience seamless transition when following proper conversion protocols under medical supervision. Some temporary adjustment in appetite control is normal during the first 1-2 weeks of switching, but this typically resolves as your body adapts to semaglutide. Weight loss patterns may differ slightly from your previous medication, but clinical trials demonstrate consistent long-term effectiveness when patients complete the full dose escalation schedule.
Cost concerns often drive switching decisions, and our transparent pricing helps you budget effectively. Unlike some suppliers who inflate prices then offer misleading "discounts," our Wegovy dose chart pricing includes all applicable savings upfront. Supply chain advantages from stocking multiple GLP-1 medications mean we rarely experience the availability issues affecting single-product pharmacies. This reliability is crucial for maintaining consistent treatment during your transition period, ensuring you never face treatment gaps that could compromise your progress.
Complete Your Switch: Start Your Wegovy Dose Chart Today
Ready to begin your Wegovy dose chart journey? Our clinical team understands the complexities of switching GLP-1 medications and provides personalised support throughout your transition. New customers benefit from code FIRST40, whilst returning patients use DOSE25 - both applied automatically at checkout to reach our competitive final prices. Visit https://everydaymeds.co.uk/collections/weight-loss to start your clinical assessment and join thousands of patients who've successfully switched to Wegovy with our support. Our comprehensive approach combines competitive pricing, clinical expertise, and reliable supply to make switching simple and successful. Don't let cost or availability concerns compromise your weight management goals when better options are available.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
